Brief: Gland Pharma Receives Approval For Angiotensin II Acetate Injection
04/06/2025 06:34
June 4 (Reuters) - Gland Pharma Ltd GLAD.NS: RECEIVES APPROVAL FOR ANGIOTENSIN II ACETATE INJECTION RECEIVES APPROVAL FROM USFDA FOR ANGIOTENSIN II ACETATE INJECTION 2.5 MG/ML Source text: ID:nnAZN3XNNVV Further company coverage: GLAD.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Gland Pharma
See all newsIndia Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln
India's Gland Pharma gains on successful completion of US FDA probe at Visakhapatnam plant